Combination treatment of Src inhibitor Saracatinib with GMI, a Ganoderma microsporum immunomodulatory protein, induce synthetic lethality via autophagy and apoptosis in lung cancer cells.

Journal of Cellular Physiology
Ling-Yen ChiuJiunn-Liang Ko

Abstract

Saracatinib is an oral Src-kinase inhibitor and has been studied in preclinical models and clinical trials of cancer therapy. GMI, a fungal immunomodulatory protein from Ganoderma microsporum, possesses antitumor capacity. The aim of this study is to evaluate the cytotoxic effect of combination treatment with saracatinib and GMI on parental and pemetrexed-resistant lung cancer cells. Cotreatment with saracatinib and GMI induced synergistic and additive cytotoxic effect in A549 and A400 cells by annexin V/propidium iodide assay and combination index. Using western blot assay, saracatinib, and GMI combined treatment synergistically induced caspase-7 activation in A549 cells. Different from A549 cells, saracatinib and GMI cotreatment markedly increased LC3B-II in A400 cells. ATG5 silencing abolished the caspase-7 activation and reduced cell death in A549 cells after cotreatment. This is the first study to provide a novel strategy of treating lung cancer with or without drug resistance via combination treatment with GMI and saracatinib.

References

Dec 15, 2000·Oncogene·R B Irby, T J Yeatman
Feb 21, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Min H Kang, C Patrick Reynolds
Jul 8, 2009·The Oncologist·Deric L WheelerEmily F Dunn
Sep 30, 2009·Nature Reviews. Clinical Oncology·Lori C KimEric B Haura
Dec 15, 2010·Autophagy·Han-Ming Shen, Patrice Codogno
Mar 29, 2012·Molecular Cancer Therapeutics·Giuliana CavalloniFrancesco Leone
Aug 17, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Fiona SimpkinsJoyce M Slingerland
Jun 25, 2014·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Julian R MolinaAlex A Adjei
Jul 4, 2016·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Sacha I RothschildMario P Tschan
Nov 24, 2018·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Chun-Te LuJiunn-Liang Ko

❮ Previous
Next ❯

Citations

Aug 12, 2021·Computational and Structural Biotechnology Journal·Albert LiHsueh-Fen Juan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptotic Caspases

Apoptotic caspases belong to the protease enzyme family and are known to play an essential role in inflammation and programmed cell death. Here is the latest research.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis